Michelle Keefe - Jan 17, 2023 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Executive Officer, Director
Signature
/s/ Sara Epstein, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Jan 17, 2023
Transactions value $
-$162,582
Form type
4
Date filed
1/19/2023, 04:31 PM
Previous filing
Dec 19, 2022
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Tax liability -$124K -3.56K -3.31% $34.76 104K Jan 17, 2023 Direct
transaction SYNH Class A Common Stock Award $0 +88K +84.56% $0.00 192K Jan 17, 2023 Direct F1
transaction SYNH Class A Common Stock Tax liability -$38.9K -1.12K -0.58% $34.80 191K Jan 18, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units which vests in three equal annual installments of 33 1/3% beginning on January 17, 2024, subject to continued employment.